Stool Transplants May Boost Immunotherapy Success in Melanoma
In patients with advanced and metastatic melanoma, fecal microbiota transplant from healthy donors given before anti–PD-1 immunotherapy led to a 75% clinical benefit rate.
MDedge News
source https://www.medscape.com/viewarticle/984710?src=rss
MDedge News
source https://www.medscape.com/viewarticle/984710?src=rss
Comments
Post a Comment